Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling.
Boyce
Brendan F
BF
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA.
Xing
Lianping
L
Chen
Di
D
D000818:Animals; D016723:Bone Remodeling; D001842:Bone and Bones / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D009154:Mutation; D010006:Osteoblasts / Q000378:metabolism; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology*; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology*; D015398:Signal Transduction; D051153:Wnt Proteins / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism*
D003598:Cytoskeletal Proteins; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; D051153:Wnt Proteins; D051176:beta Catenin